2015 sets record for Israeli mergers and acquisitions

One trend that is an increasingly important part is M&A activity between Israel and emerging markets, particularly China.

By
October 26, 2015 18:16
1 minute read.
THE TEL AVIV skyline; the area around the city is home to many Israeli start-ups

THE TEL AVIV skyline. (photo credit: REUTERS)

With two months left to go, 2015 has already broken records for mergers and acquisitions, posting a 52 percent increase over the same time period last year, according to Alain Dobkin, a managing partner of the Catalyst CEL Fund.

Moderating a panel at the annual Go4Israel investor conference in Tel Aviv, Dobkin said that M&A values have reached $21 billion so far this year. The figure, which itself sets a record, does not include the $40b. Teva acquisition of Allergan’s generic pharmaceuticals company.

Be the first to know - Join our Facebook page.


“If you look at the last six quarters in Israel, we’re basically breaking the $1b. per quarter barrier,” he said.

One trend that is an increasingly important part is M&A activity between Israel and emerging markets, particularly China.

Before 2010, there were almost no such transactions, but since there have been over $10b. worth. Chinese investors contributing to Venture Capital Financing rounds also boomed, from nonexistent in 2010 to $302 million in 2014, he said, citing figures from IVC.

French-Israeli Édouard Cukierman, chairman of Cukierman & Co. Investment House and managing partner of Catalyst Funds, which runs the conference, said that this year, more participants came from China than from Europe.

While Europe was still by far a more important trade partner, the trend was important, he said.

“It also demonstrates that we have less dependence on Chinese regarding the geopolitical situation here,” he added.


Related Content

Workers strike outside of the Teva building in Jerusalem, December 2017
December 18, 2017
Workers make explosive threats as massive Teva layoff strikes continue

By MAX SCHINDLER